Sentences with phrase «generic competition on»

The solanezumab disappointment comes at a time when Lilly is facing generic competition on several high - profile drugs, including erectile dysfunction medicine Cialis, ADHD drug Strattera and cardiovascular treatment Effient.

Not exact matches

These risks and uncertainties include, among others: the unfavorable outcome of litigation, including so - called «Paragraph IV» litigation and other patent litigation, related to any of our products or products using our proprietary technologies, which may lead to competition from generic drug manufacturers; data from clinical trials may be interpreted by the FDA in different ways than we interpret it; the FDA may not agree with our regulatory approval strategies or components of our filings for our products, including our clinical trial designs, conduct and methodologies and, for ALKS 5461, evidence of efficacy and adequacy of bridging to buprenorphine; clinical development activities may not be completed on time or at all; the results of our clinical development activities may not be positive, or predictive of real - world results or of results in subsequent clinical trials; regulatory submissions may not occur or be submitted in a timely manner; the company and its licensees may not be able to continue to successfully commercialize their products; there may be a reduction in payment rate or reimbursement for the company's products or an increase in the company's financial obligations to governmental payers; the FDA or regulatory authorities outside the U.S. may make adverse decisions regarding the company's products; the company's products may prove difficult to manufacture, be precluded from commercialization by the proprietary rights of third parties, or have unintended side effects, adverse reactions or incidents of misuse; and those risks and uncertainties described under the heading «Risk Factors» in the company's most recent Annual Report on Form 10 - K and in subsequent filings made by the company with the U.S. Securities and Exchange Commission («SEC»), which are available on the SEC's website at www.sec.gov.

The world's largest drug manufacturer is facing steep competition from a slew of smaller generic players, and the recent loss of patent protection on its major branded drug, Copaxone, is threatening Teva's profit margins.

That pressure may intensify after Pfizer's second - quarter revenue missed Wall Street estimates on Tuesday due to a decline in sales of the blockbuster pneumonia vaccine Prevnar and generic competition for Pristiq for depression.

These include patent expirations, the rise of competition from generics, a downward pressure on drug prices, increasing scrutiny from regulators and health technology assessment bodies, pressure to move research offshore, and the crisis in R&D productivity.

When Janssen Pharmaceuticals, the R&D arm of pharma giant J&J, decided they were going to focus on novel therapeutics of big impact, rather than follow the competition's focus on branded generics or biosimilars, they completely redesigned how they could tackle that goal by opening five so - called innovation centers.

Published in the Journal of Competition Law and Economics, the study shows that, on average, the percentage increase in prices is 4 - 4.5 times higher when entry - limiting deals are made and a generic is not available in the market, compared to when the generic is available but the branded and generic firms jointly set their profit - maximizing price.

* Eliminate «pay - for - delay» strategies in which a pharmaceutical company with a brand name drug shares profits on that drug with a generic drug manufacturer for the remainder of a patent period, effectively eliminating a patent challenge and competition.

This has greatly changed through time because of drug companies relying heavily on major drugs that often have problems discovered down the road or because of new branded and generic competition that didn't exist back in the early 1990s and before.

Whether it be trading on Bermuda Isles, running around and searching for turtles (leading to a challenge which, on the surface is very simple, though I found myself consistently making it difficult for myself) or pretty much falling into the generic RPG tropes of questing on behalf of someone else in order to gain money or XP and even a running competition which I still don't really understand the meaning of.

Currently, Canada is the only country that allows brand name pharmaceutical companies to sue generic pharmaceutical companies multiple times on the same patents, adding to the costs and risks of bringing generic drug competition to the Canadian market.

Having established that generic producers were potential competitors of Lundbeck, it was inevitable on the facts to regard the agreements at issue as being restrictive of competition by object.

Companies to focus on complex products as tough competition in generics, customer consolidation impact profits

Competition at the top is steep — and a resume that is generic or dated in how it describes you, and focuses on your responsibilities rather than your bottom - line impact — is not likely to bubble to the top.